HKPDVSRPRX• 28 Days (Normalized)
HKPD vs RPRX (Cellyan Biotechnology Co. Ltd vs Royalty Pharma plc)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HKPD Performance $0.13
-70.24%
Cellyan Biotechnology Co. Ltd
Normalized Baseline0.00%
RPRX Performance $58.61
+0.02%
Royalty Pharma plc
Normalized Baseline0.00%
Alpha Spread Margin RPRX LEADS
-70.26%
RPRX outperforming by 70.26%
HKPDRPRX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HKPD RPRX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | HKPD Price | HKPD Gain (%) | RPRX Price | RPRX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.13 | -70.24% | $58.61 | +0.02% | -70.26% |
| Sep 10, 2026 | $0.12 | -71.19% | $58.75 | +0.26% | -71.45% |
| Sep 09, 2026 | $0.13 | -69.52% | $60.59 | +3.40% | -72.92% |
| Sep 08, 2026 | $0.13 | -69.29% | $60.59 | +3.40% | -72.69% |
| Sep 04, 2026 | $0.13 | -69.52% | $63.96 | +9.15% | -78.67% |
| Sep 03, 2026 | $0.14 | -66.67% | $63.88 | +9.01% | -75.68% |
| Sep 02, 2026 | $0.15 | -63.81% | $63.11 | +7.70% | -71.51% |
| Sep 01, 2026 | $0.18 | -56.67% | $62.32 | +6.35% | -63.02% |
| Aug 31, 2026 | $0.33 | -20.71% | $61.41 | +4.80% | -25.51% |
| Aug 28, 2026 | $0.35 | -17.38% | $60.85 | +3.84% | -21.22% |
| Aug 27, 2026 | $0.41 | -3.33% | $61.92 | +5.67% | -9.00% |
| Aug 26, 2026 | $0.38 | -10.24% | $61.80 | +5.46% | -15.70% |
| Aug 25, 2026 | $0.40 | -5.24% | $62.07 | +5.92% | -11.16% |
| Aug 24, 2026 | $0.37 | -11.43% | $61.33 | +4.66% | -16.09% |
| Aug 21, 2026 | $0.41 | -2.62% | $61.31 | +4.62% | -7.24% |
Page 1 of 2